These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1524091)

  • 1. Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.
    Jones DV; Samaan NA; Sellin RV; Ajani JA
    Am J Med; 1992 Sep; 93(3):348-9. PubMed ID: 1524091
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of combination therapy with interferon-alpha-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours.
    Hughes MJ; Kerr DJ; Cassidy J; Soukop M; McGregor K; Blackburn N; Yosef H; Kaye SB
    Ann Oncol; 1996 Feb; 7(2):208-10. PubMed ID: 8777180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.
    Fjällskog ML; Sundin A; Westlin JE; Oberg K; Janson ET; Eriksson B
    Med Oncol; 2002; 19(1):35-42. PubMed ID: 12025889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trial.
    David AK; Vaughn DJ; Holroyde CP; Armstead B; Haller DG
    Am J Clin Oncol; 2000 Feb; 23(1):37-9. PubMed ID: 10683073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual cause for weight loss and diabetes.
    Kapoor N; Fleming JJ; Ramakrishna B; Hepzibah J; Asha HS; Chacko RT; Eapen A; Somasundaram N; Thomas N
    Hong Kong Med J; 2011 Dec; 17(6):505-6. PubMed ID: 22147325
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency].
    de Mestier L; Hammel P; Hentic O; Dove P; Lévy P; Ruszniewski P
    Gastroenterol Clin Biol; 2010 Jan; 34(1):106-10. PubMed ID: 19875259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
    Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
    Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
    Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives].
    Gómez Raposo C; Gómez Senent S; González Barón M
    Med Clin (Barc); 2007 Mar; 128(9):357; author reply 357-8. PubMed ID: 17376367
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
    Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
    Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas.
    Scheithauer W; Pfeffel F; Kornek G; Marczell A; Wiltschke C; Funovics J
    Cancer; 1992 Oct; 70(7):1864-6. PubMed ID: 1525760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of carmofur and interferon-alpha-2B in advanced gastrointestinal cancer--a phase II pilot study.
    Gröhn P; Helle L; Numminen S; Heinonen E
    Acta Oncol; 1994; 33(6):711-3. PubMed ID: 7946457
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of metastatic glucagonoma with dacarbazine.
    Kurose T; Seino Y; Ishida H; Fujita J; Taminato T; Matsukura M; Imura H
    Lancet; 1984 Mar; 1(8377):621-2. PubMed ID: 6142319
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic glucagonoma presenting as a pulmonary mass.
    Pinto Marín A; Hernández Agudo E; Feliú J; González Barón M
    Clin Transl Oncol; 2009 Jan; 11(1):60-2. PubMed ID: 19155206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors.
    Fazio N; Oberg K
    J Clin Oncol; 2004 Feb; 22(3):573-4; author reply 574-5. PubMed ID: 14752088
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.
    Ferguson JE; Hulse P; Lorigan P; Jayson G; Scarffe JH
    Br J Cancer; 1995 Jul; 72(1):193-7. PubMed ID: 7599051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of advanced pancreatic cancer with interferon alpha, tumor necrosis factor and 5-fluorouracil (preliminary report].
    Muc M; Baranowski M; Braczkowski R
    Wiad Lek; 1995; 48(1-12):198-202. PubMed ID: 9638240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
    Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
    J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
    Cascinu S; Fedeli A; Luzi Fedeli S; Catalano G
    Br J Cancer; 1994 Feb; 69(2):392-3. PubMed ID: 8297740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.